Putnam Associates

What Putnam Associates does

Putnam Associates, founded in 1988, is a privately held strategic consulting firm headquartered in Boston and serving biopharmaceutical, diagnostics, and medical device clients. The firm operates as a dedicated consulting brand within Inizio Ignite, a healthcare advisory business unit of the Inizio group that also houses Research Partnership, Vynamic, and STEM. Putnam specifically partners with pharma and life sciences organizations across four buyer constituencies: brand and commercial leaders, Medical Affairs, access and pricing teams, and R&D functions, addressing challenges from pipeline shaping through launch and post-launch performance management.

Name

Putnam Associates

Website

https://putassoc.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

251–500 employees

Short description

Putnam Associates is a Boston-based strategy consulting firm founded in 1988, operating within Inizio Ignite, that helps biopharmaceutical, diagnostics, and medical device clients with therapeutic area strategy, go-to-market planning, commercialization, pricing and access, evidence generation, and data and AI strategy decisions.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Strategy Consulting Services: Putnam provides strategy consulting services to pharmaceutical and life sciences companies, offering expertise across therapeutic area strategy, go-to-market strategy, commercialization, and market access. Revenue is generated through professional services fees for strategic advisory engagements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Putnam Associates is a strategy consulting firm serving biopharmaceutical, diagnostics, and medical device clients. It bridges science and strategy to help health and life sciences companies make confident commercial and strategic decisions across therapeutic area positioning, go-to-market planning, pricing and market access, evidence generation, and data & AI adoption. Put

Product overview

Putnam Associates, operating as part of Inizio Ignite, is a strategy consulting firm that bridges science and strategy to enable confident decision-making and build value for pharmaceutical companies. The firm operates as a single integrated consulting service brand with multiple specialized offerings including Therapeutic Area Strategy, Data & AI Strategy, Go-to-Market Strategy, Commercialization & Growth, Value Pricing & Access (VPA) Strategy, and Evidence Generation. These offerings work together to serve health and life science companies across brand & commercial, Medical Affairs, access & pricing, and R&D functions.

Differentiator

Problem solved

Functional benefit

Brands

• Putnam Strategy: Strategy consulting team that bridges science and strategy to enable confident decision-making and build value for pharma.
• Putnam Business Services
• Putnam Evidence

Products and services

• Putnam Strategy Consulting (Putnam) Strategy consulting team that bridges science and strategy to enable confident decision-making and build value for pharmaceutical companies, partnering with leading health and life sciences companies across brand & commercial, Medical Affairs, access & pricing, and R&D functions.
• Therapeutic Area Strategy Strategic formulation service that helps clients define therapeutic area positioning and competitive differentiation for biopharmaceutical products.
• Data & AI Strategy Strategic planning service that helps clients leverage data and artificial intelligence capabilities to inform pharmaceutical decision-making and competitive advantage.
• Go-to-Market Strategy Strategic planning and execution service for product launches and market entry in the health and life sciences sector.
• Commercialization & Growth Tactical decision guidance service focused on driving revenue growth and market commercialization for pharmaceutical products.
• Value, Pricing & Access (VPA) Strategy Strategic service focused on optimizing product value propositions, pricing decisions, and market access pathways for biopharmaceutical products.
• Evidence Generation Service focused on generating clinical and real-world evidence to support product value, market positioning, and strategic decision-making.

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• LEK Consulting: LEK is the most directly comparable mid-size healthcare and life sciences strategy consulting firm; it serves the same biopharma, diagnostics, and medical device client base with overlapping offerings in commercial strategy, pricing, and evidence.
• ClearView Healthcare Partners: ClearView is a focused healthcare consulting firm serving biopharma and medtech with commercial, pipeline, and portfolio strategy engagements; closely aligned with Putnam in size, sector focus, and service mix.
• Charles River Associates: CRA's Life Sciences practice provides strategy, pricing, market access, and evidence generation consulting to biopharma and medical device clients — directly mirroring Putnam's core service lines and customer base.
• ZS Associates: ZS is a major biopharma and health-focused consulting firm with deep commercial, sales, and access practices; comparable to Putnam on target customer, vertical focus, and use of data/AI-enabled advisory offerings.
• Simon-Kucher & Partners: Simon-Kucher is a specialist strategy consulting firm with a leading healthcare and life sciences practice focused on pricing, access, and commercial strategy — overlapping with Putnam's VPA and Commercialization & Growth offerings.
• Trinity Partners (now Trinity Life Sciences): Trinity provides strategy consulting, market research, and analytics to biopharma and medical device clients — covering therapeutic strategy, commercialization, and evidence work that closely overlaps with Putnam's portfolio.

Broad incumbents

• Bain & Company (Healthcare practice): Bain's Healthcare practice serves global biopharma, medtech, and diagnostics clients with commercial strategy, launch, and M&A advisory — comparable in scope to Putnam's brand & commercial and VPA offerings, but delivered as part of a broader generalist firm.
• IQVIA (Consulting & Services): IQVIA combines real-world data, clinical, and commercial advisory services for biopharma — a broader incumbent that overlaps with Putnam on commercial strategy, evidence generation, and pricing/access work at much larger scale.
• Boston Consulting Group (Healthcare practice): BCG's Health Care practice competes with Putnam across biopharma strategy, access, and transformation engagements; co-located in Boston and serving many of the same enterprise pharma clients.
• McKinsey & Company (Pharma & Medical Products): McKinsey's Pharma & Medical Products practice is a large incumbent competitor across therapeutic strategy, commercial, and transformation work — competing for the same enterprise biopharma engagements as Putnam but at significantly greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/putnamassociate
• LinkedInlinkedin.com/company/putnam-associates

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Putnam Associates